During 2020, there have been an increasing number of collaborations between multinational pharmaceutical industry, national governments, universities and biotechnology companies in the search for a COVID-19 vaccine. By June 2020, tens of billions of dollars had been invested to develop dozens of vaccine candidates and prepare for global vaccination programs. However, collaborations between different actors, with different strategic imperatives, may be challenging. In your assignment, you should look in detail at AstraZeneca’s decision to enter into this race to the creation of a working COVID-19 vaccine. There are two main related questions you should focus on:

1- Is going into the production of a COVID-19 vaccine a good strategy?

2- Is the partnership with Oxford University a wise move?

Answer rating: 100% (QA)

Description During 2020 there have been an increasing number of collaborations between multinational pharmaceutical industry national governments univ... View the full answer